Search Results

Search Results for "depuy"

• Australian lawmakers taking action on medical devices
  Australian lawmakers are considering legislation to help protect consumers from faulty medical devices, including all-metal hip implants. Newspaper The Australian reports that there is currently no requirement in Australia that sponsors of medical devices, which are companies that don’t produce th...

• J&J rebranding called well-executed PR attempt
  A story in Forbes takes a look at the trend of top global brands issuing public apologies for serious missteps. The story picks out Johnson & Johnson as an example of a company falling back on a new branding campaign in an effort to win back customers who have turned away because of recent probl...

• Israeli lawsuits filed over hip implants
  Sixty three recipients of an artificial hip implant manufactured by a Johnson & Johnson subsidiary have filed suit in Israeli court, claiming that the devices broke down and caused them pain and a high level of metal ions in their blood. According to a report in Jewish Business News, the plainti...

• J&J’s new branding a response to long-standing problems
  A piece in the New York Times on Johnson & Johnson’s new corporate branding campaign says the company urgently needed to distance itself from the “bad press of product recalls and pending litigation,” of which it experienced much lately. In 2010, the story points out, Johnson & Johnson...

• South Africans suing over hip implants
  More than 170 residents of South Africa are filing suit against Johnson & Johnson subsidiary DePuy Orthopedics over problems with the company’s all-metal hip implants, according to a story on IOL News. The story says the South African plaintiffs are suing in a court in England — where th...

• J&J trying to recover from setbacks
  Although Johnson & Johnson’s overall profit fell 10.6 percent to $3.5 billion in the first quarter of 2013, over-the-counter sales through the company’s consumer division are up 14 percent in the United States, according to a story in the Philadelphia Inquirer. The company is putting more Ty...

• Investing blog warns about J&J
  An investing blog on CNBC.com warns potential investors about health care giant Johnson & Johnson. The stock is already up more than 22 percent on the year, the blog entry says, and trading at a price/earnings ratio more than twice that of rival Abbott Laboratories. But the entry points out that...

• J&J baby powder contaminated with carcinogen
  According to a story in the International Business Times, a batch of baby powder from a Johnson & Johnson plant in India was found to be contaminated with a carcinogen. That finding prompted the Food and Drug Administration to cancel Johnson & Johnson’s license to manufacture the powder at...

• J&J undertakes campaign to repair image
  A story in Forbes describes Johnson & Johnson’s new global branding campaign, which will cost the medical products giant an estimated $20 million to $30 million for the remainder of the year. The campaign, the company’s first in more than a decade, features the tagline: “For all you love, ...

• British regulators warn about hip implants
  A story in The Telegraph details the advice that British health regulators are providing for U.K. residents who received a “metal-on-metal” hip implant, in light of recent findings that up to half of the devices fail within six years. Friction between the metal surfacing on both the implants’ ...